![Richard Geoffrion](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Richard Geoffrion was the founder of Cyrano Therapeutics, Inc. and held the titles of President, Chief Executive Officer & Director.
Richard Geoffrion active positions
Companies | Position | Start |
---|---|---|
Cyrano Therapeutics, Inc.
![]() Cyrano Therapeutics, Inc. Medical SpecialtiesHealth Technology Cyrano Therapeutics, Inc. is a clinical stage regenerative medicine company based in Delray Beach, FL. Cyrano Therapeutics is developing a novel therapy to restore smell and flavor function, with a focus on chronic smell and flavor loss caused by influenza, allergic rhinitis, traumatic brain injury, and COVID-19. The company raised a $12.80m series A financing in December 2020 led by Remiges Ventures and Ventures. The chronic loss of smell and flavor is a condition affecting at least 5% of the population with a similar incidence in and. The company was founded by Robert I. Henkin and Richard Geoffrion, with Richard Geoffrion serving as the CEO since incorporation. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Cyrano Therapeutics, Inc.
![]() Cyrano Therapeutics, Inc. Medical SpecialtiesHealth Technology Cyrano Therapeutics, Inc. is a clinical stage regenerative medicine company based in Delray Beach, FL. Cyrano Therapeutics is developing a novel therapy to restore smell and flavor function, with a focus on chronic smell and flavor loss caused by influenza, allergic rhinitis, traumatic brain injury, and COVID-19. The company raised a $12.80m series A financing in December 2020 led by Remiges Ventures and Ventures. The chronic loss of smell and flavor is a condition affecting at least 5% of the population with a similar incidence in and. The company was founded by Robert I. Henkin and Richard Geoffrion, with Richard Geoffrion serving as the CEO since incorporation. | Health Technology |
- Stock Market
- Insiders
- Richard Geoffrion